ES2051708T3 - Agente antirreumatico. - Google Patents

Agente antirreumatico.

Info

Publication number
ES2051708T3
ES2051708T3 ES87107352T ES87107352T ES2051708T3 ES 2051708 T3 ES2051708 T3 ES 2051708T3 ES 87107352 T ES87107352 T ES 87107352T ES 87107352 T ES87107352 T ES 87107352T ES 2051708 T3 ES2051708 T3 ES 2051708T3
Authority
ES
Spain
Prior art keywords
antirheumatic agent
neolactonoroctaosilceramide
glucolipids
antirheumatic
trifucosil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87107352T
Other languages
English (en)
Inventor
Takahiro Ochi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2051708T3 publication Critical patent/ES2051708T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

AGENTE ANTIRREUMATICO CONTENIENDO, COMO INGREDIENTE ACTIVO, UN GLUCOLIPIDO ESPECIFICO, COMO DIFUCOSIL NEOLACTONOROCTAOSILCERAMIDA O TRIFUCOSIL NEOLACTONOROCTAOSILCERAMIDA. DICHOS GLUCOLIPIDOS SON CONOCIDOS COMPONENTES QUE ESTAN AISLADOS DE LA ADENOCARCINOMA HUMANA. SIN EMBARGO, HASTA LA FECHA, NO SE CONOCIA QUE ESTOS GLUCOLIPIDOS POSEEN ALGUNAS ACTIVIDADES FARMACOLOGICAS RELATIVAS A LA ARTRITIRS REUMATOIDE. DICHO AGENTE ANTIRREUMATICO SE USA PREFERENTEMENTE COMO PREPARACIONES FARMACEUTICAS INYECTABLES.
ES87107352T 1986-05-21 1987-05-20 Agente antirreumatico. Expired - Lifetime ES2051708T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61116703A JPS62273919A (ja) 1986-05-21 1986-05-21 抗リウマチ剤

Publications (1)

Publication Number Publication Date
ES2051708T3 true ES2051708T3 (es) 1994-07-01

Family

ID=14693741

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87107352T Expired - Lifetime ES2051708T3 (es) 1986-05-21 1987-05-20 Agente antirreumatico.

Country Status (6)

Country Link
US (1) US4914085A (es)
EP (1) EP0250831B1 (es)
JP (1) JPS62273919A (es)
DE (1) DE3781045T2 (es)
DK (1) DK255487A (es)
ES (1) ES2051708T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH024801A (ja) * 1988-06-23 1990-01-09 Rikagaku Kenkyusho 新規なスフィンゴ糖脂質関連化合物及びその製造法
US5753631A (en) * 1990-06-15 1998-05-19 Cytel Corporation Intercellular adhesion mediators
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
WO1997037682A1 (en) * 1996-04-10 1997-10-16 Cytel Corporation Nucleic acids encoding gdp-fucose pyrophosphorylase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2076418A (en) * 1980-05-22 1981-12-02 Sankyo Co Hydrolyzed polysaccharide
FR2509313A1 (fr) * 1981-07-08 1983-01-14 Choay Sa Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
DE3347522A1 (de) * 1983-12-30 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法

Also Published As

Publication number Publication date
EP0250831B1 (en) 1992-08-12
EP0250831A3 (en) 1989-11-29
JPH0374646B2 (es) 1991-11-27
JPS62273919A (ja) 1987-11-28
EP0250831A2 (en) 1988-01-07
US4914085A (en) 1990-04-03
DE3781045D1 (de) 1992-09-17
DK255487D0 (da) 1987-05-20
DE3781045T2 (de) 1993-03-04
DK255487A (da) 1987-11-22

Similar Documents

Publication Publication Date Title
FR2433337B1 (fr) Compositions cosmetiques, en particulier fonds de teint aqueux
NL188500C (nl) Extern botverankeringssamenstel.
ES2019942B3 (es) Tratamiento de formaciones subterraneas que contienen hierro.
IT7968615A0 (it) Procedimento di estrazione selettiva dell uranio da una soluzione acquosa contenente vari actinidi
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
DE3776499D1 (de) Schienbein-prothese.
IT7921418A0 (it) Analoghi della 6,9-metano-pgi2.
NL980035I1 (nl) Benzimidazolen, de bereiding daarvan en deze verbindingen bevattende geneesmiddelen.
ES2044840T3 (es) Composiciones estabilizadas del activador del plasminogeno de tejido humano.
DE3776722D1 (de) Stabilisierte polyacetalzusammensetzungen.
BE857645A (fr) Composition explosive aqueuse perfectionnee et son obtention.
BG104536A (en) Antiperspirant with dibenzylidene sorbitol
ES2018259B3 (es) Estructuras de tierra estabilizada.
ES2054643T3 (es) Un procedimiento para la despolimerizacion controlada de polisacaridos.
ES2051708T3 (es) Agente antirreumatico.
NL7811747A (nl) Tand-implantaat.
IT8119297A0 (it) Procedimento di iniezione e diformazione della miscela, come pure dispositivo per la realizzazione dello stesso.
ES8100079A1 (es) Un metodo para la obtencion de una composicion vitrea para implantacion subcutanea en animales de crianza domestica
IT1105005B (it) Composizione stabilizzata di resina contenente cloro
BR8009111A (pt) Protese de ossos do ouvido
IT8023262A0 (it) Composizioni farmaceutiche contenenti estratti di edera rampicante.
GR73158B (es)
BE873279A (fr) Systeme de construction utilisant des elements prefabriques
ES542835A0 (es) Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer.
NO782924L (no) Fremgangsmaate for solubilisering av fd&c roed nr. 3

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 250831

Country of ref document: ES